Cargando…

Cost‐effectiveness analysis of primary human papillomavirus testing in cervical cancer screening: Results from the HPV FOCAL Trial

The Human Papillomavirus FOr CervicAL cancer (HPV FOCAL) trial is a large randomized controlled trial comparing the efficacy of primary HPV testing to cytology among women in the population‐based Cervix Screening Program in British Columbia, Canada. We conducted a cost‐effectiveness analysis based o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cromwell, Ian, Smith, Laurie W., van der Hoek, Kim, Hedden, Lindsay, Coldman, Andrew J., Cook, Darrel, Franco, Eduardo L., Krajden, Mel, Martin, Ruth, Lee, Marette H., Stuart, Gavin, van Niekerk, Dirk, Ogilvie, Gina, Peacock, Stuart
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085916/ https://www.ncbi.nlm.nih.gov/pubmed/33811457 http://dx.doi.org/10.1002/cam4.3864

Ejemplares similares

Human papillomavirus‐based screening at extended intervals missed fewer cervical precancers than cytology in the HPV For Cervical Cancer (HPV FOCAL) trial
por: Gottschlich, Anna, et al.
Publicado: (2022)

Women’s acceptability of and experience with primary human papillomavirus testing for cervix screening: HPV FOCAL trial cross-sectional online survey results
por: Smith, Laurie W, et al.
Publicado: (2021)

A randomized controlled trial of Human Papillomavirus (HPV) testing for cervical cancer screening: trial design and preliminary results (HPV FOCAL Trial)
por: Ogilvie, Gina S, et al.
Publicado: (2010)

Disease detection and resource use in the safety and control arms of the HPV FOCAL cervical cancer screening trial
por: Coldman, Andrew J, et al.
Publicado: (2016)

Comparison of the Roche cobas® 4800 and Digene Hybrid Capture® 2 HPV tests for primary cervical cancer screening in the HPV FOCAL trial
por: Cook, Darrel A., et al.
Publicado: (2015)

Willingness to Self-Collect a Sample for HPV-Based Cervical Cancer Screening in a Well-Screened Cohort: HPV FOCAL Survey Results
por: Lesack, Anne, et al.
Publicado: (2022)

Evaluation of a validated methylation triage signature for human papillomavirus positive women in the HPV FOCAL cervical cancer screening trial
por: Cook, Darrel A., et al.
Publicado: (2018)

Colposcopy referral rates post-introduction of primary screening with human papillomavirus testing: evidence from a large British Columbia cohort study
por: Gottschlich, Anna, et al.
Publicado: (2023)

Primary cervical cancer screening with HPV testing compared with liquid-based cytology: results of round 1 of a randomised controlled trial – the HPV FOCAL Study
por: Ogilvie, G S, et al.
Publicado: (2012)

Women’s intentions to self-collect samples for human papillomavirus testing in an organized cervical cancer screening program
por: Smith, Laurie W, et al.
Publicado: (2014)

Correlates of women’s intentions to be screened for human papillomavirus for cervical cancer screening with an extended interval
por: Ogilvie, Gina S., et al.
Publicado: (2016)

Sociodemographic characteristics of women with invasive cervical cancer in British Columbia, 2004–2013: a descriptive study
por: Simkin, Jonathan, et al.
Publicado: (2021)

Awareness and knowledge of Human Papillomavirus (HPV), HPV‐related cancers, and HPV vaccines in an uninsured adult clinic population
por: Radecki Breitkopf, Carmen, et al.
Publicado: (2016)

Cervical Intraepithelial Neoplasia Rates in British Columbia Women: A Population-Level Data Linkage Evaluation of the School-Based HPV Immunization Program
por: Racey, C Sarai, et al.
Publicado: (2020)

Age-Specific Trends of Invasive Cervical Cancer Incidence in British Columbia, Canada, 1971–2017
por: Raveinthiranathan, Nivedha, et al.
Publicado: (2023)

Dysregulation of host cellular genes targeted by human papillomavirus (HPV) integration contributes to HPV‐related cervical carcinogenesis
por: Zhang, Ruiyang, et al.
Publicado: (2016)

Prevalence of high‐risk human papillomavirus after HPV‐vaccination in Denmark
por: Lynge, Elsebeth, et al.
Publicado: (2020)

Detection of Early Sero-Conversion HIV Infection Using the INSTI(TM) HIV-1 Antibody Point-of-Care Test
por: Cook, Darrel, et al.
Publicado: (2010)

Human papillomavirus genotypes in cervical and other HPV‐related anogenital cancer in Rwanda, according to HIV status
por: Mpunga, Tharcisse, et al.
Publicado: (2019)

HSV-2 infection and HPV incidence, persistence, and precancerous lesions in a cohort of HPV-vaccinated women living with HIV
por: McClymont, Elisabeth, et al.
Publicado: (2023)

Impact of human papillomaviruses (HPV) on recurrence rate and malignant progression of sinonasal papillomas
por: Paehler vor der Holte, Anja, et al.
Publicado: (2020)

The Path to Eliminating Cervical Cancer in Canada: Past, Present and Future Directions
por: Caird, Hannah, et al.
Publicado: (2022)

Immunogenicity of 2 and 3 Doses of the Quadrivalent Human Papillomavirus Vaccine up to 120 Months Postvaccination: Follow-up of a Randomized Clinical Trial
por: Donken, Robine, et al.
Publicado: (2020)

Community-randomised controlled trial embedded in the Anishinaabek Cervical Cancer Screening Study: human papillomavirus self-sampling versus Papanicolaou cytology
por: Zehbe, Ingeborg, et al.
Publicado: (2016)

Human papillomavirus (HPV) in Chinese oropharyngeal squamous cell carcinoma (OPSCC): A strong predilection for the tonsil
por: Xu, Tingting, et al.
Publicado: (2020)

Serial type-specific human papillomavirus (HPV) load measurement allows differentiation between regressing cervical lesions and serial virion productive transient infections
por: Depuydt, Christophe E, et al.
Publicado: (2015)

Mortality among British Columbians testing for hepatitis C antibody
por: Yu, Amanda, et al.
Publicado: (2013)

Public awareness of the association between human papillomavirus and oropharyngeal cancer
por: Verhees, Femke, et al.
Publicado: (2021)

Worldwide burden of cancer attributable to HPV by site, country and HPV type
por: de Martel, Catherine, et al.
Publicado: (2017)

Pharmacists’ Attitudes and Perceived Barriers to Human Papillomavirus (HPV) Vaccination Services
por: Hastings, Tessa J., et al.
Publicado: (2017)

Molecular heterogeneity in human papillomavirus‐dependent and ‐independent vulvar carcinogenesis
por: Swarts, Dorian R. A., et al.
Publicado: (2018)

Efficacy of careHPV™ human papillomavirus screening versus conventional cytology tests for the detection of precancerous and cancerous cervical lesions among women living with HIV‐1 in Lao People's Democratic Republic
por: Paboriboune, Phimpha, et al.
Publicado: (2022)

Human Papillomavirus (HPV)-Associated Cancers Among Hispanic Males in the United States: Late-Stage Diagnosis by Country of Origin
por: Villalona, Seiichi, et al.
Publicado: (2023)

Psychosocial determinants of parental human papillomavirus (HPV) vaccine decision-making for sons: Methodological challenges and initial results of a pan-Canadian longitudinal study
por: Perez, Samara, et al.
Publicado: (2016)

Characterization of key transcription factors as molecular signatures of HPV‐positive and HPV‐negative oral cancers
por: Verma, Gaurav, et al.
Publicado: (2017)

‘Real-world’ health care priority setting using explicit decision criteria: a systematic review of the literature
por: Cromwell, Ian, et al.
Publicado: (2015)

Targeting screening and social marketing to increase detection of acute HIV infection in men who have sex with men in Vancouver, British Columbia
por: Gilbert, Mark, et al.
Publicado: (2013)

Self-Collected versus Clinician-Collected Sampling for Chlamydia and Gonorrhea Screening: A Systemic Review and Meta-Analysis
por: Lunny, Carole, et al.
Publicado: (2015)

Absent/weak CD44 intensity and positive human papillomavirus (HPV) status in oropharyngeal squamous cell carcinoma indicates a very high survival
por: Näsman, Anders, et al.
Publicado: (2013)

HPV-positive oropharyngeal squamous cell carcinoma is associated with TIMP3 and CADM1 promoter hypermethylation
por: van Kempen, Pauline M W, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_q3m01lnatiheblsmvtiugjlf1d